Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Macrocheilia, granulomatous cheilitis and Crohn's disease].
Portela Romero M, Ventura Victoria MA, Iglesias Otero M, do Muiño Joga M, Bugarín González R. Portela Romero M, et al. Semergen. 2013 Nov-Dec;39(8):450-2. doi: 10.1016/j.semerg.2012.07.008. Epub 2012 Sep 13. Semergen. 2013. PMID: 24315077 Spanish.
Effect of Previous Anticoagulant Treatment on Risk of COVID-19.
Zapata-Cachafeiro M, Prieto-Campo Á, Portela-Romero M, Carracedo-Martínez E, Lema-Oreiro M, Piñeiro-Lamas M, Chaudhuri S, Salgado-Barreira Á, Figueiras A. Zapata-Cachafeiro M, et al. Drug Saf. 2023 Mar;46(3):273-281. doi: 10.1007/s40264-022-01266-0. Epub 2022 Dec 23. Drug Saf. 2023. PMID: 36562942 Free PMC article.
Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study.
Prieto-Campo Á, Zapata-Cachafeiro M, Portela-Romero M, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Prieto-Campo Á, et al. Among authors: portela romero m. Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00014-8. doi: 10.1016/j.rec.2023.12.004. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38191054 Free article. English, Spanish.
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Inflammopharmacology. 2024 Apr 15. doi: 10.1007/s10787-024-01475-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38619761
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.
Rodríguez-Fernández A, Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, García-Álvarez RM, Herdeiro TM, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á; COVIDRUG Group. Rodríguez-Fernández A, et al. Inflammopharmacology. 2024 May 2. doi: 10.1007/s10787-024-01474-3. Online ahead of print. Inflammopharmacology. 2024. PMID: 38698179
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry.
López-Otero D, López-Pais J, Cacho-Antonio CE, Antúnez-Muiños PJ, González-Ferrero T, Pérez-Poza M, Otero-García Ó, Díaz-Fernández B, Bastos-Fernández M, Bouzas-Cruz N, Sanmartín-Pena XC, Varela-Román A, Portela-Romero M, Valdés-Cuadrado L, Pose-Reino A, González-Juanatey JR. López-Otero D, et al. Rev Esp Cardiol (Engl Ed). 2021 Feb;74(2):175-182. doi: 10.1016/j.rec.2020.05.018. Epub 2020 Jun 5. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32600991 Free PMC article.
48 results